These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33274688)

  • 1. Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats.
    Uzuneser TC; Weiss EM; Dahlmanns J; Kalinichenko LS; Amato D; Kornhuber J; Alzheimer C; Hellmann J; Kaindl J; Hübner H; Löber S; Gmeiner P; Grömer TW; Müller CP
    J Psychopharmacol; 2021 Jan; 35(1):65-77. PubMed ID: 33274688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats.
    Uzuneser TC; Schindehütte M; Dere E; von Hörsten S; Kornhuber J; Grömer TW; Müller CP
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1382-1393. PubMed ID: 30243682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.
    Tucker KR; Block ER; Levitan ES
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4485-94. PubMed ID: 26216995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of heat-shock protein HSP-70 and glutamate transporter-1/glutamine synthetase in the striatum and hippocampus in haloperidol-induced dopamine-supersensitivity-state rats.
    Kimura M; Oda Y; Hirose Y; Kimura H; Yoshino K; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
    Pharmacol Biochem Behav; 2021 Dec; 211():173288. PubMed ID: 34653399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.
    Tadokoro S; Okamura N; Sekine Y; Kanahara N; Hashimoto K; Iyo M
    Schizophr Bull; 2012 Sep; 38(5):1012-20. PubMed ID: 21402722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor.
    Guma E; Rocchetti J; Devenyi GA; Tanti A; Mathieu A; Lerch JP; Elgbeili G; Courcot B; Mechawar N; Chakravarty MM; Giros B
    Neuroimage; 2018 Aug; 176():226-238. PubMed ID: 29704613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.
    Bédard AM; Maheux J; Lévesque D; Samaha AN
    Schizophr Bull; 2013 May; 39(3):692-702. PubMed ID: 22927669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration.
    Guma E; Rocchetti J; Devenyi GA; Tanti A; Mathieu AP; Lerch JP; Elgbeili G; Courcot B; Mechawar N; Chakravarty MM; Giros B
    Sci Rep; 2019 May; 9(1):7850. PubMed ID: 31127135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
    Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
    Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
    Huang N; Ase AR; Hébert C; van Gelder NM; Reader TA
    Neurochem Int; 1997 Mar; 30(3):277-90. PubMed ID: 9041559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis.
    Oda Y; Tadokoro S; Takase M; Kanahara N; Watanabe H; Shirayama Y; Hashimoto K; Iyo M
    J Psychopharmacol; 2015 Dec; 29(12):1308-13. PubMed ID: 26174132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does antagonism at 5-HT2A receptors potentiate D₂ blockade-induced disruption of conditioned avoidance response?
    Gao J; Huang Y; Li M
    Exp Clin Psychopharmacol; 2019 Apr; 27(2):103-108. PubMed ID: 30556732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure.
    Chestnykh DA; Amato D; Kornhuber J; Müller CP
    Behav Brain Res; 2021 Apr; 403():113144. PubMed ID: 33515642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL/6 mice.
    Donahue TJ; Webster KA; Hillhouse TM; De Oliveira EO; Porter JH
    Behav Pharmacol; 2019 Sep; 30(6):521-528. PubMed ID: 31058657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
    El Hage C; Bédard AM; Samaha AN
    Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats.
    Ohno Y; Ishibashi T; Okada K; Ishida K; Nakamura M
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Oct; 19(6):1091-101. PubMed ID: 8584685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
    Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
    Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?
    Arad M; Weiner I
    Neuropsychopharmacology; 2010 Jun; 35(7):1570-82. PubMed ID: 20237462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.